Doctor of Dentistry Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Ali Al-Qudsi

Oral & Maxillofacial Surgery Chicago, IL Doctor of Dentistry

NPI 1518528165 CMS profile 5954502

1901 W Harrison St, Chicago, IL 60612

Open in the dashboard

General payments

$4,061

34 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Ali Al-Qudsi of Chicago, IL is reported in the CMS Open Payments database as having received $4,061 across 34 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 81st percentile of Oral & Maxillofacial Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $109 2
2024 General $1,508 14
2023 General $743 5
2022 General $244 4
2021 General $224 3
2020 General $749 4
2019 General $485 2

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Ali Al-Qudsi
  • Oral & Maxillofacial Surgery median
  • Middle half of Oral & Maxillofacial Surgery
  • National median

In program year 2025, general payments to Ali Al-Qudsi were reported at $109. Among 792 Oral & Maxillofacial Surgery profiles paid that year, the median was $184 and the middle half received between $61 and $541.

Show as a table
Year Ali Al-Qudsi Oral & Maxillofacial Surgery median Middle half National median
2019 $485 $178 $56–$584 $163
2020 $749 $106 $38–$316 $114
2021 $224 $165 $57–$511 $132
2022 $244 $173 $63–$494 $149
2023 $743 $184 $62–$521 $160
2024 $1,508 $197 $65–$603 $164
2025 $109 $184 $61–$541 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Stryker Corporation $2,194 20 payments
  2. Medical Device Business Services, Inc. $1,153 6 payments
  3. Dentsply Sirona Inc $204 2 payments
  4. Geistlich Pharma, North America, Inc. $185 1 payment
  5. Nobel Biocare USA $111 1 payment
  6. Straumann USA LLC $95 1 payment
  7. AxoGen $81 1 payment
  8. KLS-Martin L.P. $26 1 payment
  9. BioHorizons Implant Systems Inc. $14 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Education $1,479 7 payments
  2. Food and Beverage $1,355 21 payments
  3. Travel and Lodging $1,133 5 payments
  4. Gift $95 1 payment
Products named General payments · program years 2019–2025
  1. NA Neuro $1,340 11 payments
  2. UNIVERSAL MANDIBLE $326 1 payment
  3. VSP SYSTEM, VSP CRANIAL $269 3 payments
  4. ASTRA TECH Implant System $204 2 payments
  5. Bio-Gide $185 1 payment
  6. PATIENT-FITTED TMJ RECONSTRUCTIVE PROSTHESIS SYSTEM $163 1 payment
  7. NA Craniomaxillofacial $140 1 payment
  8. NOBELACTIVE $111 1 payment
  9. Avance Nerve Graft $81 1 payment
  10. AxoGuard Nerve Connector $81 1 payment
  11. Other $191 6 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 6 drugs

Part D claims

239

Median for Oral & Maxillofacial Surgery: 284

Drug cost

$795

Median for Oral & Maxillofacial Surgery: $1,067

Branded share of claims

15.1%

Median for Oral & Maxillofacial Surgery: 17.7%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Acetaminophen-Codeine Acetaminophen With Codeine Brand 36 $218
Amoxicillin Generic 67 $197
Chlorhexidine Gluconate Generic 44 $149
Ibuprofen Generic 64 $134
Methylprednisolone Generic 15 $84
Tramadol Hcl Generic 13 $13

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 600 Part D prescribers listed as Oral & Maxillofacial Surgery; they describe a distribution and say nothing about conduct.

Records

34 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Oral & Maxillofacial Surgery in Illinois

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record